Nanosonics is largely a single-product firm, and its Trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures... Show more
NNCSF's Aroon Indicator triggered a bullish signal on November 04, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 108 similar instances where the Aroon Indicator showed a similar pattern. In of the 108 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Momentum Indicator moved above the 0 level on November 11, 2025. You may want to consider a long position or call options on NNCSF as a result. In of 50 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The 10-day RSI Indicator for NNCSF moved out of overbought territory on October 27, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 similar instances where the indicator moved out of overbought territory. In of the 18 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Moving Average Convergence Divergence Histogram (MACD) for NNCSF turned negative on October 27, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NNCSF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
NNCSF broke above its upper Bollinger Band on October 16, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NNCSF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.341) is normal, around the industry mean (10.086). P/E Ratio (65.409) is within average values for comparable stocks, (153.436). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.600). NNCSF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (6.798) is also within normal values, averaging (110.982).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NNCSF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
Industry PharmaceuticalsOther
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JNUSX | 19.95 | -0.07 | -0.35% |
| JPMorgan Developed International Value L | |||
| TIGCX | 21.72 | -0.21 | -0.96% |
| Thornburg International Growth C | |||
| PJEQX | 15.63 | -0.16 | -1.01% |
| PGIM US Real Estate R6 | |||
| MFQAX | 18.40 | -0.22 | -1.18% |
| AMG Veritas Global Focus N | |||
| JAGIX | 80.52 | -1.38 | -1.68% |
| Janus Henderson Growth And Income T | |||
A.I.dvisor tells us that NNCSF and ASAPF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NNCSF and ASAPF's prices will move in lockstep.
| Ticker / NAME | Correlation To NNCSF | 1D Price Change % | ||
|---|---|---|---|---|
| NNCSF | 100% | N/A | ||
| ASAPF - NNCSF | 21% Poorly correlated | -1.21% | ||
| NHNKY - NNCSF | 8% Poorly correlated | -6.44% | ||
| NHNKF - NNCSF | 0% Poorly correlated | N/A | ||
| NVYTF - NNCSF | 0% Poorly correlated | N/A | ||
| MRCHF - NNCSF | 0% Poorly correlated | N/A | ||
More | ||||
| Ticker / NAME | Correlation To NNCSF | 1D Price Change % |
|---|---|---|
| NNCSF | 100% | N/A |
| Pharmaceuticals category (378 stocks) | 3% Poorly correlated | -0.99% |
| Pharmaceuticals: Other category (103 stocks) | 2% Poorly correlated | -1.40% |